Multiple Sclerosis Medications Innovations
A illness during which the system chow away at the protecting covering of nerves.In MS, ensuing nerve harm disrupts communication between the
brain and also the body.Multiple sclerosis causes many alternative symptoms, as well as vision loss, pain, fatigue and impaired coordination. The symptoms, severity and length will vary from person to person. Some individuals could also be symptom free for many of their lives, whereas others will have severe, chronic symptoms that ne'er get away.Physiotherapy and medicine that suppress the system will facilitate with symptoms, and slow illness progress.Multiple sclerosis causes many alternative symptoms, as well as vision loss, pain, fatigue and impaired coordination. The symptoms, severity and length will vary from person to person. Some individuals could also be symptom free for many of their lives, whereas others will have severe, chronic symptoms that ne'er get away.
High Impact List of Articles
-
A retrospective study of Spondylodiscitis with clinical, imaging and therapeutic correlations
Barbara Brogna*, Alessandra Coppola, Elio Bignardi
Research Article: Clinical Investigation
-
A retrospective study of Spondylodiscitis with clinical, imaging and therapeutic correlations
Barbara Brogna*, Alessandra Coppola, Elio Bignardi
Research Article: Clinical Investigation
-
Turoctocog alfa in the treatment of individuals with hemophilia A: review of quality of life data collected in Phase III trials
Stephanie Seremetis, Roshni Kulkarni, Antoine Regnault & Elena Santagostino
Review: Clinical Trail Outcomes: Clinical Investigation
-
Turoctocog alfa in the treatment of individuals with hemophilia A: review of quality of life data collected in Phase III trials
Stephanie Seremetis, Roshni Kulkarni, Antoine Regnault & Elena Santagostino
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
CHILD-INNOVAC project demonstrates effective nasal vaccine against pertussis in Phase I trial
News and Views: Clinical Investigation
-
CHILD-INNOVAC project demonstrates effective nasal vaccine against pertussis in Phase I trial
News and Views: Clinical Investigation
-
Measuring symptoms as a critical component of drug development and evaluation in hematological diseases
Loretta A Williams, Emre Yucel, Jorge E Cortes,Charles S Cleeland
Review Article: Clinical Investigation
-
Measuring symptoms as a critical component of drug development and evaluation in hematological diseases
Loretta A Williams, Emre Yucel, Jorge E Cortes,Charles S Cleeland
Review Article: Clinical Investigation
Relevant Topics in Clinical